首页 > 最新文献

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru最新文献

英文 中文
[Gastrointestinal hemorrhage as an uncommon form of presentation of primary intestinal amyloidosis: case report]. [作为原发性肠淀粉样变性不常见表现形式的消化道出血:病例报告]。
Jorge Luis Fernández Luque, Juan Eloy Paredes Méndez, Ricardo Alejandro Rocha Bolaños, Jéssica Tatheana Matheus Sairitupac

Intestinal amyloidosis is a rare and underdiagnosed systemic disease, which is characterized by the extracellular deposition of proteins that are grouped into amyloid fibers. This entity is rare and is usually a form of presentation in the context of systemic amyloidosis, the diagnosis of which is based on the presence of amyloid in histology. The clinic is usually non-specific; chronic diarrhea, weight loss, abdominal pain and bloating; Gastrointestinal bleeding is a very rare manifestation. The case of a 61-year-old woman with symptoms of weight loss, abdominal distension, nausea, vomiting and long hair is presented. Tomographically, a wall thickening of jejunal loops with contrast uptake was evidenced, a finding that was corroborated by a double-balloon anterograde stereoscopy in which multiple were evidenced. The pathology shows distorted and ulcerated villous architecture with positive histochemistry for Congo Red and LAMBDA (+++) immunohistochemistry. In addition, bone marrow aspirate and bone biopsy compatible with infiltration of Lambda chain monoclonal multiple myeloma were performed. During the hospital stay, the patient developed complications such as chronic malnutrition, recurrent infection and several episodes of intestinal subocclusion; characterized by intestinal pneumatosis; due to multiple episodes of these complications, the patient died. Within clinical practice in gastroenterology, intestinal amyloidosis as part of the differential diagnosis of upper gastrointestinal bleeding is infrequent, so a history of diagnosis of multiple myeloma or other monoclonal gammopathy associated with light chains is crucial for early diagnosis and adequate treatment.

肠淀粉样变性是一种罕见且诊断率低的全身性疾病,其特征是细胞外沉积的蛋白质聚集成淀粉样纤维。这种疾病非常罕见,通常是全身性淀粉样变性的一种表现形式,其诊断依据是组织学中淀粉样蛋白的存在。临床表现通常是非特异性的;慢性腹泻、体重减轻、腹痛和腹胀;消化道出血是非常罕见的表现。本病例是一名 61 岁的妇女,其症状为体重减轻、腹胀、恶心、呕吐和长头发。断层扫描显示空肠襻壁增厚并伴有造影剂摄取,双球囊前向立体镜检查证实了这一发现,其中可见多个空肠襻。病理检查显示绒毛结构扭曲和溃疡,组织化学刚果红和LAMBDA(+++)免疫组化阳性。此外,还进行了骨髓抽吸和骨活检,结果与 Lambda 链单克隆多发性骨髓瘤的浸润相符。住院期间,患者出现了一些并发症,如慢性营养不良、反复感染和数次肠道下闭塞;其特点是肠道积气;由于多次出现这些并发症,患者最终死亡。在消化内科的临床实践中,肠淀粉样变性作为上消化道出血鉴别诊断的一部分并不常见,因此多发性骨髓瘤或其他与轻链相关的单克隆抗体病的诊断史对于早期诊断和适当治疗至关重要。
{"title":"[Gastrointestinal hemorrhage as an uncommon form of presentation of primary intestinal amyloidosis: case report].","authors":"Jorge Luis Fernández Luque, Juan Eloy Paredes Méndez, Ricardo Alejandro Rocha Bolaños, Jéssica Tatheana Matheus Sairitupac","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Intestinal amyloidosis is a rare and underdiagnosed systemic disease, which is characterized by the extracellular deposition of proteins that are grouped into amyloid fibers. This entity is rare and is usually a form of presentation in the context of systemic amyloidosis, the diagnosis of which is based on the presence of amyloid in histology. The clinic is usually non-specific; chronic diarrhea, weight loss, abdominal pain and bloating; Gastrointestinal bleeding is a very rare manifestation. The case of a 61-year-old woman with symptoms of weight loss, abdominal distension, nausea, vomiting and long hair is presented. Tomographically, a wall thickening of jejunal loops with contrast uptake was evidenced, a finding that was corroborated by a double-balloon anterograde stereoscopy in which multiple were evidenced. The pathology shows distorted and ulcerated villous architecture with positive histochemistry for Congo Red and LAMBDA (+++) immunohistochemistry. In addition, bone marrow aspirate and bone biopsy compatible with infiltration of Lambda chain monoclonal multiple myeloma were performed. During the hospital stay, the patient developed complications such as chronic malnutrition, recurrent infection and several episodes of intestinal subocclusion; characterized by intestinal pneumatosis; due to multiple episodes of these complications, the patient died. Within clinical practice in gastroenterology, intestinal amyloidosis as part of the differential diagnosis of upper gastrointestinal bleeding is infrequent, so a history of diagnosis of multiple myeloma or other monoclonal gammopathy associated with light chains is crucial for early diagnosis and adequate treatment.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"43 4","pages":"358-363"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Esophageal foreign bodies: review of 84 cases]. [食管异物:84 例病例回顾]。
Cristian Flórez Sarmiento, Viviana Parra Izquierdo, Juan Sebastian Frías Ordoñez, Jesús David Castillo, Eliana Murcia Monroy, Lidsay Delgado Cardona, Charlyn Stefani Rodríguez

The presence of esophageal foreign body (EFB) is a common emergency in gastroenterology. The protocol for management and endoscopic intervention can be variable among institutions.

Objective: to define the clinical characteristics of EFB in adults, its radiological and endoscopic diagnosis, and complications based on a sample of patients in a gastroenterology center.

Materials and methods: case series of patients admitted from the emergency department and referred to the gastroenterology department with a presumptive diagnosis of EFB. Clinical variables were collected, as well as characteristics, comorbidities, time of evolution and diagnostic opportunity, confirmatory studies, and complications.

Results: 84 subjects, 70% men, mean age 45 (range: 17-87; SD 12.5) years. Urgent upper endoscopy was performed in 98.8% of the patients, with an average in-hospital stay of 2.5 days. 93% had no associated underlying pathology, in 6/84 (7.14%) patients structural or functional esophageal pathology was documented. 59/84 (70.2%) patients consulted in the first 24 hours, in 57.6% the presence of foreign body was confirmed endoscopically. In 67/84 (79.76%) patients radiography was performed prior to endoscopy, of which 62/67 (92.5%) had an abnormal result. Seventy percent of confirmed EFB were fish bones. The most frequent site of localization was in the cricopharyngeal region in 90% of the cases. In 66/84 (78.6%) subjects there was absence of complications, followed by deep laceration in 10/84 (11.9%) cases. In 3/84 (3.6%) cases complications requiring surgery were identified.

Conclusions: Endoscopic intervention in the first 24 hours is an opportune moment to identify complications and provide the indicated treatment.

食管异物(EFB)是消化内科常见的急症。材料和方法:对急诊科收治并转诊至消化内科、推测诊断为 EFB 的患者进行病例系列分析。收集临床变量、特征、合并症、演变时间和诊断机会、确诊研究和并发症:84名受试者中,70%为男性,平均年龄45岁(范围:17-87岁;标准差12.5岁)。98.8%的患者接受了急诊上内镜检查,平均住院时间为2.5天。93%的患者没有相关的潜在病变,6/84(7.14%)的患者有食管结构性或功能性病变记录。59/84(70.2%)名患者在最初的 24 小时内就诊,其中 57.6% 的患者通过内镜确认了异物的存在。67/84(79.76%)名患者在内镜检查前进行了放射检查,其中 62/67(92.5%)名患者的检查结果异常。在确诊的 EFB 中,70% 为鱼骨。最常见的定位部位是环咽区,占 90%。在 66/84 例(78.6%)受检者中没有出现并发症,其次是 10/84 例(11.9%)出现深度裂伤。3/84(3.6%)的病例出现了需要手术的并发症:结论:在最初的 24 小时内进行内窥镜干预是发现并发症并提供相应治疗的最佳时机。
{"title":"[Esophageal foreign bodies: review of 84 cases].","authors":"Cristian Flórez Sarmiento, Viviana Parra Izquierdo, Juan Sebastian Frías Ordoñez, Jesús David Castillo, Eliana Murcia Monroy, Lidsay Delgado Cardona, Charlyn Stefani Rodríguez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The presence of esophageal foreign body (EFB) is a common emergency in gastroenterology. The protocol for management and endoscopic intervention can be variable among institutions.</p><p><strong>Objective: </strong>to define the clinical characteristics of EFB in adults, its radiological and endoscopic diagnosis, and complications based on a sample of patients in a gastroenterology center.</p><p><strong>Materials and methods: </strong>case series of patients admitted from the emergency department and referred to the gastroenterology department with a presumptive diagnosis of EFB. Clinical variables were collected, as well as characteristics, comorbidities, time of evolution and diagnostic opportunity, confirmatory studies, and complications.</p><p><strong>Results: </strong>84 subjects, 70% men, mean age 45 (range: 17-87; SD 12.5) years. Urgent upper endoscopy was performed in 98.8% of the patients, with an average in-hospital stay of 2.5 days. 93% had no associated underlying pathology, in 6/84 (7.14%) patients structural or functional esophageal pathology was documented. 59/84 (70.2%) patients consulted in the first 24 hours, in 57.6% the presence of foreign body was confirmed endoscopically. In 67/84 (79.76%) patients radiography was performed prior to endoscopy, of which 62/67 (92.5%) had an abnormal result. Seventy percent of confirmed EFB were fish bones. The most frequent site of localization was in the cricopharyngeal region in 90% of the cases. In 66/84 (78.6%) subjects there was absence of complications, followed by deep laceration in 10/84 (11.9%) cases. In 3/84 (3.6%) cases complications requiring surgery were identified.</p><p><strong>Conclusions: </strong>Endoscopic intervention in the first 24 hours is an opportune moment to identify complications and provide the indicated treatment.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"43 4","pages":"328-333"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatotoxicidad por tamsulosina / dutasterida: reporte de un caso probable 坦索洛辛/杜他雄胺的肝毒性:一例可能病例的报告
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1544
Stalin Yance, Pedro Montes
La tamsulosina y dutasterida son medicamentos ampliamente usados como tratamiento de la hipertrofia benigna de próstata. teniendo un buen perfil de seguridad. Existen escasos reportes de injuria hepática asociado al uso de tamsulosina; sin embargo, no hay reportes de toxicidad hepática por el uso de dutasterida y del uso combinado de tamsulosina/dutasterida. Se presenta el caso de un varón de 64 años quien desarrolla injuria hepática tras el uso combinado de tamsulosina/dutasterida, desarrollando un patrón de daño hepatocelular y clínica de hepatitis aguda. Se realizo descarte de patología hepática viral, autoinmune y enfermedades metabólicas de depósito, así como de patología biliar mediante ecografía abdominal y colangioresonancia. En la evaluación de causalidad, presentó CIOMS-RUCAM: 6 puntos (probable) y Naranjo: 4 puntos (posible). El paciente presentó respuesta clínica y laboratorial luego de suspender el medicamento.
坦索洛辛和杜他雄胺是广泛用于治疗良性前列腺肥大的药物。具有良好的安全特性。很少有与坦索洛辛相关的肝损伤的报道;然而,目前还没有使用杜他雄胺和坦索洛辛/杜他雄胺联合使用的肝毒性报道。本研究的目的是评估坦索洛辛/杜他雄胺联合使用后的肝损伤,并评估急性肝炎的临床和肝细胞损伤模式。本研究的目的是评估一种疾病的临床表现,这种疾病的特征是肝脏疾病、自身免疫性疾病和代谢储存疾病,以及胆道疾病。在因果评估中,CIOMS-RUCAM: 6分(可能)和Naranjo: 4分(可能)。患者在停药后出现临床和实验室反应。
{"title":"Hepatotoxicidad por tamsulosina / dutasterida: reporte de un caso probable","authors":"Stalin Yance, Pedro Montes","doi":"10.47892/rgp.2023.433.1544","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1544","url":null,"abstract":"La tamsulosina y dutasterida son medicamentos ampliamente usados como tratamiento de la hipertrofia benigna de próstata. teniendo un buen perfil de seguridad. Existen escasos reportes de injuria hepática asociado al uso de tamsulosina; sin embargo, no hay reportes de toxicidad hepática por el uso de dutasterida y del uso combinado de tamsulosina/dutasterida. Se presenta el caso de un varón de 64 años quien desarrolla injuria hepática tras el uso combinado de tamsulosina/dutasterida, desarrollando un patrón de daño hepatocelular y clínica de hepatitis aguda. Se realizo descarte de patología hepática viral, autoinmune y enfermedades metabólicas de depósito, así como de patología biliar mediante ecografía abdominal y colangioresonancia. En la evaluación de causalidad, presentó CIOMS-RUCAM: 6 puntos (probable) y Naranjo: 4 puntos (posible). El paciente presentó respuesta clínica y laboratorial luego de suspender el medicamento.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Frequency of functional esophageal disorders in patients with refractory reflux symptoms in Lima, Peru 秘鲁利马难治性反流症状患者功能性食管疾病的发生率
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1498
Luis Piza-Palacios, Mercedes Cárdenas-Oña, Ximena Vásquez-Ojeda, Carmen Alurralde, Edith Rosas, Frine Samalvides-Cuba, Jorge Espinoza-Ríos
Gastroesophageal reflux disease (GERD) is a clinical condition in which gastric reflux causes symptoms or damage to the esophageal mucosa. It is managed with proton pump inhibitors, however, up to 45% of patients with suspected GERD are refractory to treatment. It is necessary to establish a true GERD diagnosis by means of a digestive endoscopy, which does not show lesions in approximately 70% of patients. In this scenario, it is necessary to perform an esophageal pH-impedance measurement, a procedure that allows to determine whether exposure to gastric acid is pathological. Of this group, patients with pathological acid exposure are diagnosed as true non-erosive reflux disease (NERD). If, in addition to not presenting esophageal lesions, they have a physiological exposure to gastric acid, they suffer from esophageal hypersensitivity or functional heartburn, which are functional disorders. These require a different approach from that of GERD or NERD, as the symptoms are not due to pathological exposure to gastric acid. The aim was to calculate the frequency of esophageal hypersensitivity and functional heartburn in patients with suspected NERD. This was a cross-sectional study. Data was collected by reviewing pH-impedance and manometry reports, 166 patients were selected. The frequency for functional disorders was 86.15%, being 46.9% for functional heartburn and 39.2% for esophageal hypersensitivity. The frequency of functional disorders was higher than that reported in previous studies. In conclusion, age, psychological conditions, dietary, cultural, ethnic or lifestyle factors inherent to our environment might play important roles in the development of functional disorders.
胃食管反流病(GERD)是一种胃反流引起症状或损害食管黏膜的临床疾病。然而,高达45%的疑似胃食管反流患者难以治疗。有必要通过消化内窥镜检查来确定真正的GERD诊断,大约70%的患者没有显示病变。在这种情况下,有必要进行食管ph阻抗测量,这一过程可以确定胃酸暴露是否为病理性的。在该组中,病理性酸暴露的患者被诊断为真正的非糜烂性反流病(NERD)。如果他们除了没有出现食道病变外,还有生理上的胃酸暴露,他们会出现食道过敏或功能性烧心,这些都是功能性疾病。由于这些症状不是由于病理性的胃酸暴露,因此需要不同于GERD或NERD的治疗方法。目的是计算疑似NERD患者食管超敏反应和功能性胃灼热的频率。这是一项横断面研究。通过查阅ph阻抗和测压报告收集数据,共选取166例患者。功能性障碍发生率为86.15%,其中功能性烧心46.9%,食管超敏39.2%。功能障碍的发生率高于以往的研究报告。总之,年龄、心理状况、饮食、文化、种族或生活方式等环境因素可能在功能障碍的发展中发挥重要作用。
{"title":"Frequency of functional esophageal disorders in patients with refractory reflux symptoms in Lima, Peru","authors":"Luis Piza-Palacios, Mercedes Cárdenas-Oña, Ximena Vásquez-Ojeda, Carmen Alurralde, Edith Rosas, Frine Samalvides-Cuba, Jorge Espinoza-Ríos","doi":"10.47892/rgp.2023.433.1498","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1498","url":null,"abstract":"Gastroesophageal reflux disease (GERD) is a clinical condition in which gastric reflux causes symptoms or damage to the esophageal mucosa. It is managed with proton pump inhibitors, however, up to 45% of patients with suspected GERD are refractory to treatment. It is necessary to establish a true GERD diagnosis by means of a digestive endoscopy, which does not show lesions in approximately 70% of patients. In this scenario, it is necessary to perform an esophageal pH-impedance measurement, a procedure that allows to determine whether exposure to gastric acid is pathological. Of this group, patients with pathological acid exposure are diagnosed as true non-erosive reflux disease (NERD). If, in addition to not presenting esophageal lesions, they have a physiological exposure to gastric acid, they suffer from esophageal hypersensitivity or functional heartburn, which are functional disorders. These require a different approach from that of GERD or NERD, as the symptoms are not due to pathological exposure to gastric acid. The aim was to calculate the frequency of esophageal hypersensitivity and functional heartburn in patients with suspected NERD. This was a cross-sectional study. Data was collected by reviewing pH-impedance and manometry reports, 166 patients were selected. The frequency for functional disorders was 86.15%, being 46.9% for functional heartburn and 39.2% for esophageal hypersensitivity. The frequency of functional disorders was higher than that reported in previous studies. In conclusion, age, psychological conditions, dietary, cultural, ethnic or lifestyle factors inherent to our environment might play important roles in the development of functional disorders.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracción endoscópica de banda gástrica migrada 内镜下切除移位的胃束带
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1395
Juan Antonio Chirinos-Vega, Eduardo Vesco-Monteagudo, Patricia Valera-Luján, Aurelio Barboza-Beraún
Se reporta el caso de una paciente mujer de 47 años, portadora de una banda gástrica ajustable desde el año 2018, quien presenta dolor abdominal por migración intragástrica de la misma, pudiendo extraerla exitosamente via endoscópica con ayuda de litotriptor de Sohendra.
报告一例47岁女性患者,自2018年起佩戴可调节胃带,因胃内迁移而出现腹痛,可在Sohendra碎石机的帮助下通过内镜成功取出。
{"title":"Extracción endoscópica de banda gástrica migrada","authors":"Juan Antonio Chirinos-Vega, Eduardo Vesco-Monteagudo, Patricia Valera-Luján, Aurelio Barboza-Beraún","doi":"10.47892/rgp.2023.433.1395","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1395","url":null,"abstract":"Se reporta el caso de una paciente mujer de 47 años, portadora de una banda gástrica ajustable desde el año 2018, quien presenta dolor abdominal por migración intragástrica de la misma, pudiendo extraerla exitosamente via endoscópica con ayuda de litotriptor de Sohendra.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis: A systematic review of randomized controlled trials 鼻胃管与鼻空肠管喂养治疗重症急性胰腺炎:随机对照试验的系统综述
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1542
Andrea Carlin-Ronquillo, Harold Benites-Goñi, Carlos Diaz-Arocutipa, Paulo Alosilla Sandoval, Alejandro Piscoya-Rivera, Lesly Calixto, Adrian V. Hernández
Early enteral nutrition through a feeding tube is essential for the management of severe acute pancreatitis (SAP). Nasojejunal tube nutrition has been preferred on the assumption that it provided pancreatic rest in comparison to the nasogastric tube. However, nasojejunal tube placement is complex, may delay feeding initiation and can increase hospital costs. Our aim was to compare the efficacy and safety of enteral feeding with a nasogastric tube versus nasojejunal tube in patients with SAP. We searched four databases (PubMed, Web of Science, Scopus, and Embase) until December 1, 2022. We included randomized controlled trials (RCTs) comparing enteral feeding by nasogastric and nasojejunal tubes in patients with SAP. Primary outcome was all-cause mortality. Secondary outcomes were organ failure, infection, complications, surgical intervention, duration of tube feeding and length of hospital stay. Risk of bias assessment was completed independently by two investigators using the Cochrane RoB 2.0 tool. We performed random effects model meta-analyses using the inverse variance method. Effect measures were reported as relative risks (RR) and their 95% CIs for dichotomous outcomes and mean differences (MD) and their 95% CIs for continuous outcomes. We included four RCTs involving 192 patients with SAP. The mean ages ranged between 36 and 62 years old. There was no significant difference in all-cause mortality between the nasogastric and nasojejunal feeding arms (18/98 vs. 23/93; RR 1.34, 95%CI 0.77–2.30; p=0.30). There were no significant differences in all secondary outcomes between feeding arms. There were three RCTs with some concerns of bias, in the randomization process. In conclusion, in patients with SAP, enteral feeding delivered by nasogastric tube was as efficacious and safe as nasojejunal tube. Further randomized controlled trials with more participants and better design are needed to confirm these findings.
早期通过饲管进行肠内营养对于重症急性胰腺炎(SAP)的治疗至关重要。与鼻胃管相比,鼻空肠管营养更能提供胰腺休息。然而,鼻空肠管放置是复杂的,可能延迟喂养开始,并可能增加医院费用。我们的目的是比较鼻胃管与鼻空肠管在SAP患者中肠内喂养的有效性和安全性。我们检索了四个数据库(PubMed, Web of Science, Scopus和Embase),直到2022年12月1日。我们纳入了比较SAP患者鼻胃管和鼻空肠管肠内喂养的随机对照试验(rct)。主要结局是全因死亡率。次要结局为器官衰竭、感染、并发症、手术干预、管饲持续时间和住院时间。偏倚风险评估由两名研究者使用Cochrane RoB 2.0工具独立完成。我们使用逆方差法对随机效应模型进行meta分析。效果测量报告为相对危险度(RR)及其二分结局的95% ci和平均差异(MD)及其连续结局的95% ci。我们纳入了4项随机对照试验,涉及192例SAP患者,平均年龄在36 - 62岁之间。鼻胃喂养组和鼻空肠喂养组的全因死亡率无显著差异(18/98 vs. 23/93;Rr 1.34, 95%ci 0.77-2.30;p = 0.30)。各喂养组的所有次要结果均无显著差异。在随机化过程中,有三个rct存在一定的偏倚。综上所述,在SAP患者中,鼻胃管肠内喂养与鼻空肠管一样安全有效。需要更多参与者和更好设计的进一步随机对照试验来证实这些发现。
{"title":"Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis: A systematic review of randomized controlled trials","authors":"Andrea Carlin-Ronquillo, Harold Benites-Goñi, Carlos Diaz-Arocutipa, Paulo Alosilla Sandoval, Alejandro Piscoya-Rivera, Lesly Calixto, Adrian V. Hernández","doi":"10.47892/rgp.2023.433.1542","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1542","url":null,"abstract":"Early enteral nutrition through a feeding tube is essential for the management of severe acute pancreatitis (SAP). Nasojejunal tube nutrition has been preferred on the assumption that it provided pancreatic rest in comparison to the nasogastric tube. However, nasojejunal tube placement is complex, may delay feeding initiation and can increase hospital costs. Our aim was to compare the efficacy and safety of enteral feeding with a nasogastric tube versus nasojejunal tube in patients with SAP. We searched four databases (PubMed, Web of Science, Scopus, and Embase) until December 1, 2022. We included randomized controlled trials (RCTs) comparing enteral feeding by nasogastric and nasojejunal tubes in patients with SAP. Primary outcome was all-cause mortality. Secondary outcomes were organ failure, infection, complications, surgical intervention, duration of tube feeding and length of hospital stay. Risk of bias assessment was completed independently by two investigators using the Cochrane RoB 2.0 tool. We performed random effects model meta-analyses using the inverse variance method. Effect measures were reported as relative risks (RR) and their 95% CIs for dichotomous outcomes and mean differences (MD) and their 95% CIs for continuous outcomes. We included four RCTs involving 192 patients with SAP. The mean ages ranged between 36 and 62 years old. There was no significant difference in all-cause mortality between the nasogastric and nasojejunal feeding arms (18/98 vs. 23/93; RR 1.34, 95%CI 0.77–2.30; p=0.30). There were no significant differences in all secondary outcomes between feeding arms. There were three RCTs with some concerns of bias, in the randomization process. In conclusion, in patients with SAP, enteral feeding delivered by nasogastric tube was as efficacious and safe as nasojejunal tube. Further randomized controlled trials with more participants and better design are needed to confirm these findings.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inicio de nutrición enteral luego de una gastrostomía endoscópica, ¿es necesario esperar 内窥镜胃造口术后开始肠内营养,是否需要等待
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1552
William Otero-Regino, Hernando Marulanda-Fernández, Gilberto Jaramillo-Trujillo, Lina Otero-Parra, Julián Parga-Bermúdez, Felipe Vera-Polanía, Juan Antonio Trejos-Naranjo, Elder Otero Ramos
Tradicionalmente, el inicio de nutrición enteral, luego de una gastrostomía endoscópica percutánea (GEP) se realiza entre 12 a 24 horas. Diferentes investigaciones sugieren que iniciarla más temprano podría ser una opción segura. El objetivo es determinar si el inicio de nutrición enteral a las 4 horas después de realizar GEP es una conducta segura en cuanto al riesgo de intolerancia, complicaciones o muerte, comparado con iniciarla a las 12 horas. Realizamos un estudio prospectivo, aleatorizado, multicéntrico en instituciones de tercer y cuarto nivel de Bogotá y Cundinamarca, entre junio de 2020 y mayo de 2022, se incluyeron 117 pacientes que fueron aleatorizados en 2 grupos, el grupo A de inicio temprano de nutrición (4 horas), y el grupo B de inicio estándar (12 horas). El mecanismo más frecuente de disfagia fue la enfermedad cerebrovascular (43%), seguido por complicaciones de infección por COVID-19 (26%). No hubo diferencias estadísticamente significativas entre los grupos evaluados respecto al porcentaje de intolerancia a la nutrición, RR = 0,93 (IC 0,30-2,90), tampoco hubo diferencias en términos de complicaciones posoperatorias, (RR) = 0,34 (IC 0,09-1,16), y no se encontraron diferencias en la mortalidad entre los grupos evaluados, (RR) = 1,12 (IC 0,59 – 2,15). En conclusión, el inicio de nutrición a través de la gastrostomía de forma temprana, 4 horas después de la realización de la GEP es una conducta segura que no se relaciona con una mayor intolerancia a la nutrición, complicaciones o muerte, en comparación con un inicio más tardío.
传统上,经皮内窥镜胃造口术(GEP)后开始肠内营养需要12到24小时。不同的研究表明,尽早开始可能是一个安全的选择。目的是确定在GEP后4小时开始肠内营养与在12小时开始肠内营养相比,在不耐受、并发症或死亡风险方面是否安全。机构开展了前瞻性的研究,随机,multicéntrico波哥大(bogota)第三和第四级别和昆迪纳马卡省,到2022年6月至2020年5月,列入了117名患者被随机分为2组:A组较早开始营养(4小时)标准,而B组(12小时)。吞咽困难最常见的机制是脑血管疾病(43%),其次是COVID-19感染并发症(26%)。没有显著的统计学差异群体评估营养比例方面的不容忍,RR = 0.93 (ci 0,30-2,90)而言,也有差异)= RR posoperatorias并发症(0.34 (IC 0,09-1,16)。没有发现差异评估群体死亡率(RR) = 1,12 (IC 0.59—2,15)。综上所述,在GEP完成后4小时内通过胃造口术开始营养是一种安全的行为,与较晚开始营养不耐受、并发症或死亡无关。
{"title":"Inicio de nutrición enteral luego de una gastrostomía endoscópica, ¿es necesario esperar","authors":"William Otero-Regino, Hernando Marulanda-Fernández, Gilberto Jaramillo-Trujillo, Lina Otero-Parra, Julián Parga-Bermúdez, Felipe Vera-Polanía, Juan Antonio Trejos-Naranjo, Elder Otero Ramos","doi":"10.47892/rgp.2023.433.1552","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1552","url":null,"abstract":"Tradicionalmente, el inicio de nutrición enteral, luego de una gastrostomía endoscópica percutánea (GEP) se realiza entre 12 a 24 horas. Diferentes investigaciones sugieren que iniciarla más temprano podría ser una opción segura. El objetivo es determinar si el inicio de nutrición enteral a las 4 horas después de realizar GEP es una conducta segura en cuanto al riesgo de intolerancia, complicaciones o muerte, comparado con iniciarla a las 12 horas. Realizamos un estudio prospectivo, aleatorizado, multicéntrico en instituciones de tercer y cuarto nivel de Bogotá y Cundinamarca, entre junio de 2020 y mayo de 2022, se incluyeron 117 pacientes que fueron aleatorizados en 2 grupos, el grupo A de inicio temprano de nutrición (4 horas), y el grupo B de inicio estándar (12 horas). El mecanismo más frecuente de disfagia fue la enfermedad cerebrovascular (43%), seguido por complicaciones de infección por COVID-19 (26%). No hubo diferencias estadísticamente significativas entre los grupos evaluados respecto al porcentaje de intolerancia a la nutrición, RR = 0,93 (IC 0,30-2,90), tampoco hubo diferencias en términos de complicaciones posoperatorias, (RR) = 0,34 (IC 0,09-1,16), y no se encontraron diferencias en la mortalidad entre los grupos evaluados, (RR) = 1,12 (IC 0,59 – 2,15). En conclusión, el inicio de nutrición a través de la gastrostomía de forma temprana, 4 horas después de la realización de la GEP es una conducta segura que no se relaciona con una mayor intolerancia a la nutrición, complicaciones o muerte, en comparación con un inicio más tardío.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generación de un test predictivo para el diagnóstico de la etiología de la hemorragia digestiva alta variceal 生成诊断静脉曲张上消化道出血病因的预测试验
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1460
Luis Yasser Pérez-Condori, Arnold Esthif Alvarado-Malca, César Antonio Loza-Munarriz, Jorge Luis Espinoza-Río
Nuestro objetivo fue desarrollar un test diagnóstico para predecir la etiología de la Hemorragia Digestiva Alta Variceal (HDAV). Realizamos un estudio de cohorte retrospectivo. Se revisaron historias clínicas de pacientes mayores de 18 años con Hemorragia Digestiva Alta (HDA) que acudieron al servicio de emergencia del Hospital Cayetano Heredia (HCH) de Lima-Perú entre el 2019 a 2022, se recolectaron datos demográficos, de laboratorio y clínicos; posteriormente, se identificaron variables predictivas de HDAV mediante una regresión logística múltiple. A cada variable con capacidad predictiva se les asignó un puntaje con un punto de corte y sirvió para construir una escala predictiva de HDAV. Se incluyeron 197 historias clínicas de pacientes con HDA, de los cuales 127 (64%) tuvieron sangrado de causa no variceal, y, 70 (36%), variceal. Se identificaron 4 factores predictivos independientes: hematemesis (vómito rojo) (OR: 4,192, IC 95%: 1,586-11,082), recuento de plaquetas (OR: 3,786, IC 95%: 1,324-10,826), antecedente de HDA (OR: 2,634, IC 95%: 1,017-6,820), signos de enfermedad hepática crónica (OR: 11,244, IC 95%: 3,067-35,047), con los que se construyó una escala predictiva, con un punto de corte >7 y ≤7; que mostró una sensibilidad, especificidad, valor predictivo positivo, valor predictivo negativo, cociente de probabilidad positivo, y, negativo de 58,6%, 90,6%, 77,4%, 79,9%, 6,20, y 0,46 respectivamente. En conclusión, la escala predictiva con un punto de corte >7 es útil para predecir la presencia de la HDAV en pacientes que acuden a la emergencia por HDA.
我们的目的是开发一种诊断测试来预测静脉曲张上消化道出血(HDAV)的病因。我们进行了一项回顾性队列研究。我们回顾了2019年至2022年在秘鲁利马卡耶塔诺埃雷迪亚医院(HCH)急诊室就诊的18岁以上上消化道出血(HDA)患者的临床病史,收集了人口统计学、实验室和临床数据;随后,采用多元logistic回归方法确定HDAV的预测变量。每个具有预测能力的变量被分配一个带有分界点的分数,用于构建HDAV预测量表。我们纳入了197例HDA患者的病史,其中127例(64%)非静脉曲张引起的出血,70例(36%)静脉曲张引起的出血。确定了红4独立预测因素:hematemesis(呕吐)(OR: 4,192, 95% ci: - 1,586-11,082)、血小板计数(OR: 3,786, 95% ci: - 1,324-10,826 HDA),前期(OR: 2,634, 95% ci: - 1,017-6,820),慢性肝脏疾病迹象(OR: 11.244, 95% ci: - 3,067-35,047),与预测规模上建造的,符号;7法院和≤7点;敏感性、特异性、阳性预测值、阴性预测值、阳性概率和阴性概率分别为58.6%、90.6%、77.4%、79.9%、6.20、0.46。最后,截止点> 7的预测量表有助于预测HDA急诊患者中HDAV的存在。
{"title":"Generación de un test predictivo para el diagnóstico de la etiología de la hemorragia digestiva alta variceal","authors":"Luis Yasser Pérez-Condori, Arnold Esthif Alvarado-Malca, César Antonio Loza-Munarriz, Jorge Luis Espinoza-Río","doi":"10.47892/rgp.2023.433.1460","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1460","url":null,"abstract":"Nuestro objetivo fue desarrollar un test diagnóstico para predecir la etiología de la Hemorragia Digestiva Alta Variceal (HDAV). Realizamos un estudio de cohorte retrospectivo. Se revisaron historias clínicas de pacientes mayores de 18 años con Hemorragia Digestiva Alta (HDA) que acudieron al servicio de emergencia del Hospital Cayetano Heredia (HCH) de Lima-Perú entre el 2019 a 2022, se recolectaron datos demográficos, de laboratorio y clínicos; posteriormente, se identificaron variables predictivas de HDAV mediante una regresión logística múltiple. A cada variable con capacidad predictiva se les asignó un puntaje con un punto de corte y sirvió para construir una escala predictiva de HDAV. Se incluyeron 197 historias clínicas de pacientes con HDA, de los cuales 127 (64%) tuvieron sangrado de causa no variceal, y, 70 (36%), variceal. Se identificaron 4 factores predictivos independientes: hematemesis (vómito rojo) (OR: 4,192, IC 95%: 1,586-11,082), recuento de plaquetas (OR: 3,786, IC 95%: 1,324-10,826), antecedente de HDA (OR: 2,634, IC 95%: 1,017-6,820), signos de enfermedad hepática crónica (OR: 11,244, IC 95%: 3,067-35,047), con los que se construyó una escala predictiva, con un punto de corte &gt;7 y ≤7; que mostró una sensibilidad, especificidad, valor predictivo positivo, valor predictivo negativo, cociente de probabilidad positivo, y, negativo de 58,6%, 90,6%, 77,4%, 79,9%, 6,20, y 0,46 respectivamente. En conclusión, la escala predictiva con un punto de corte &gt;7 es útil para predecir la presencia de la HDAV en pacientes que acuden a la emergencia por HDA.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vanek’s tumor: a rare differential diagnosis of colonic submucosal lesions Vanek肿瘤:结肠粘膜下病变的罕见鉴别诊断
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1534
Diego Berrospi-Castillo, Elsy Sotomayor-Trelles, Harold Benites Goñi
Gastrointestinal submucosal lesions represent a diagnostic challenge, including benign or malignant lesions, so they are identified more accurately by histopathological study accompanied by immunohistochemistry. This is a case of a 21-year-old man with a bleeding submucosal lesion in the cecum. The patient underwent a right colectomy. Microscopic finding was compatible with Vanek's tumor.
胃肠道粘膜下病变是一种诊断挑战,包括良性或恶性病变,因此通过组织病理学研究结合免疫组织化学更准确地识别它们。这是一个21岁的男性病例,在盲肠粘膜下病变出血。病人接受了右结肠切除术。显微镜下的发现与瓦内克的肿瘤相符。
{"title":"Vanek’s tumor: a rare differential diagnosis of colonic submucosal lesions","authors":"Diego Berrospi-Castillo, Elsy Sotomayor-Trelles, Harold Benites Goñi","doi":"10.47892/rgp.2023.433.1534","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1534","url":null,"abstract":"Gastrointestinal submucosal lesions represent a diagnostic challenge, including benign or malignant lesions, so they are identified more accurately by histopathological study accompanied by immunohistochemistry. This is a case of a 21-year-old man with a bleeding submucosal lesion in the cecum. The patient underwent a right colectomy. Microscopic finding was compatible with Vanek's tumor.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curar a veces, aliviar a menudo, consolar siempre 有时治愈,经常缓解,总是安慰
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1615
Hugo Guillermo Cedrón-Cheng
-
-
{"title":"Curar a veces, aliviar a menudo, consolar siempre","authors":"Hugo Guillermo Cedrón-Cheng","doi":"10.47892/rgp.2023.433.1615","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1615","url":null,"abstract":"-","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1